Outcomes for Patients with Clinical Lymphadenopathy Treated with Radical Prostatectomy.
暂无分享,去创建一个
F. Montorsi | G. Gandaglia | A. Briganti | R. Karnes | M. Moschini | R. Carlson | M. Bianchi | E. Kwon | J. Quevedo | C. Murphy
[1] U. Capitanio,et al. More extensive pelvic lymph node dissection improves survival in patients with node-positive prostate cancer. , 2015, European urology.
[2] R. Phillips. Bladder cancer: Stem cells repopulate tumours , 2015, Nature Reviews Urology.
[3] Cesare Cozzarini,et al. Impact of adjuvant radiotherapy on survival of patients with node-positive prostate cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] F. Montorsi,et al. Predicting survival of patients with node-positive prostate cancer following multimodal treatment. , 2014, European urology.
[5] P. Scardino,et al. Long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapy. , 2014, European urology.
[6] Marco Bianchi,et al. Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection. , 2012, European urology.
[7] Misop Han,et al. Predicting 15-year prostate cancer specific mortality after radical prostatectomy. , 2011, The Journal of urology.
[8] E. Bergstralh,et al. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era. , 2007, The Journal of urology.
[9] Jorge Yao,et al. Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy. , 2006, The Lancet. Oncology.